Speed and safety: the dual advantage of sutureless aortic valve implants

HIGHLIGHTS Sutureless aortic valve replacement offers quicker implantation and reduced procedural times. Sutureless aortic valve replacement significantly improves hemodynamics with no structural valve deterioration observed. Sutureless valves are associated with lower stroke rates and reduced paravalvular leakage. Sutureless valves lead to overall cost savings due to shorter hospital stays and reduced postoperative care. Reduced aortic cross-clamp and cardiopulmonary bypass times minimize complication risks. Sutureless aortic valve replacement represents a transformative advancement in cardiac surgery, particularly for patients at high surgical risk or those requiring complex procedures[1,2]. This innovation, exemplified by the Perceval bioprosthesis, allows for quicker implantation, reduced procedural times, and potentially improved hemodynamics, making it a promising option for a diverse patient population[3,4]. A recent comprehensive analysis of midterm clinical results highlighted the efficacy and safety of sutureless valves[5]. The study involved 113 patients with symptomatic severe aortic stenosis who underwent sutureless aortic valve replacement using the Perceval valve and reported a 5-year overall survival rate of 95.9%. These patients, predominantly elderly with a mean age of 75.3 years, showed substantial postoperative improvements in left ventricular mass index and mean pressure gradient. Notably, no cases of structural valve deterioration or significant paravalvular leakage were observed during the follow-up period. Furthermore, the SURE-AVR registry, which included over 1600 patients, revealed that sutureless valves are associated with low rates of early adverse events and excellent long-term outcomes[6-8]. For instance, the mean aortic pressure gradient decreased significantly from 37.6 mmHg preoperatively to 13.0 mmHg at discharge, with the effective orifice area nearly doubling from 0.7 to 1.4 cm2. Comparative studies have further highlighted the advantages of sutureless valves. For example, a meta-analysis found that the stroke rate was lower in the sutureless group (0–3.7%) compared to sutured valves (1.8–7.3%), and the incidence of moderate/severe paravalvular leak was significantly lower for sutureless valves (1–19.4%) compared to sutured valves (0–1%)[8]. Moreover, the cost analysis indicates that sutureless valves, despite their initial expense, can lead to overall cost savings due to shorter hospital stays and reduced need for postoperative care[9,10]. Patients implanted with the Perceval valve had a mean length of hospital stay of 14.2 days, which is relatively short given the complexity of their conditions[6]. The procedural benefits of sutureless valves extend beyond the clinical outcomes. Reduced aortic cross-clamp and cardiopulmonary bypass times are critical to minimize the risk of complications, particularly in high-risk patients. In a high-volume center study, the mean aortic cross-clamp time for sutureless valve implantation was significantly lower than that of traditional methods, highlighting the efficiency of this approach[1]. From a surgical perspective, the learning curve associated with sutureless valve implantation is relatively steep but manageable. Studies suggest that as surgeons gain experience, the procedural times decrease, and outcomes improve, facilitating broader clinical adoption[8]. The advent of transcatheter aortic valve replacement (TAVR) has influenced the landscape of valve replacement therapy. While TAVR offers a minimally invasive option for inoperable or high-risk patients, it is associated with higher rates of paravalvular leakage and concerns about long-term durability compared with sutureless valves[11,12]. Overall, the integration of sutureless valves into clinical practice marks a significant advancement in cardiac surgery. The combination of improved hemodynamics, reduced procedural times, and favorable long-term outcomes makes sutureless valves a compelling option for aortic valve replacement, particularly in high-risk populations[8]. Continued research and longitudinal studies will further elucidate the full potential and long-term benefits of this innovative technology, paving the way for broader clinical application and improved patient care. The future of aortic valve replacement is likely to be significantly influenced by the continued development and refinement of sutureless valve technology. Ongoing research and clinical trials will provide more data on long-term outcomes, optimal patient selection, and comparative effectiveness with other valve types such as TAVR. Moreover, the expanding indications for sutureless valves, including their use in younger, lower-risk patients, will further solidify their role in cardiac surgery. The potential for reduced procedural times and improved hemodynamics makes sutureless valves attractive options for a wide range of patients. In conclusion, sutureless aortic valve replacement represents a transformative approach to the treatment of aortic stenosis, offering a viable and often superior alternative to traditional surgical methods. With ongoing advancements and accumulating clinical evidence, the future of aortic valve replacement has been poised to be significantly shaped by this innovative technology.